(Q39390921)

English

Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: a multicenter, randomized, double-blind, phase III study in North America

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Intratumoral cisplatin/epinephrine gel in advanced head and neck cancer: a multicenter, randomized, double-blind, phase III study in North America (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

multicenter clinical trial

0 references

head and neck cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

advanced head and neck cancer

1 reference

based on heuristic

inferred from title

head and neck carcinoma

1 reference

based on heuristic

inferred from title

author name string

Dan J Castro

1

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Kasi S Sridhar

2

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Harinder S Garewal

3

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Glenn M Mills

4

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Barry L Wenig

5

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Frank R Dunphy

6

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Peter D Costantino

7

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Richard D Leavitt

8

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Morgan E Stewart

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Elaine K Orenberg

10

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

717-731

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Induction Chemotherapy with Vinblastine, Bleomycin, and cis‐Diamminedichloroplatinum in Squamous Cell Carcinoma of the Head and Neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

21 January 2018

Re-irradiation of head and neck tumors. Benefits and toxicities.

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cisplatin in advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose cisplatin for locally advanced or metastatic head and neck cancer. A phase II pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of highly selective supradose cisplatin infusions for advanced head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Regional chemotherapy with combined drugs in cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Intra-arterial continuous infusion of cis-diamminedichloroplatinum in untreated head and neck cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Results in 169 patients with cancer of the head and neck treated by intra-arterial infusion therapy

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical Chemotherapy of Cutaneous Malignancy of the Head and Neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of intratumorous bleomycin-A5 injection for head and neck lymphangioma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Kinetics of57Co-bleomycin in mice after intravenous, subcutaneous and intratumoral injection

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Topical administration of cisplatin in far-advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Polymer delivery of chemotherapy for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical and immunopathological results of a phase II study of perilymphatically injected recombinant interleukin-2 in locally far advanced, nonpretreated head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

"Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. I. Histoculture experiments.

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

"Decadose" effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studies

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of cisplatin-resistant COLO 316 human ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens.

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Injectable modalities as local and regional strategies for head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of surgical complications after organ-preservation therapy in patients with stage III or IV squamous cell head and neck cancer

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Postoperative radiation therapy for primary vs. recurrent squamous cell carcinoma of the head and neck: results of a comparative analysis

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictors of response and survival after concurrent chemotherapy and radiation for locally advanced squamous cell carcinomas of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2FHED.10261

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/HED.10261

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39390921&oldid=1824637676"